People: Illumina Inc (ILMN.O)

ILMN.O on Nasdaq

215.98USD
11:05am EDT
Change (% chg)

$-1.29 (-0.59%)
Prev Close
$217.27
Open
$219.45
Day's High
$219.79
Day's Low
$215.44
Volume
339,145
Avg. Vol
1,410,648
52-wk High
$242.37
52-wk Low
$145.12

Search Stocks

Dadswell, Charles 

Mr. Charles E. Dadswell is Senior Vice President, General Counsel, Secretary of Illumina, Inc., since April 22, 2013. Mr. Dadswell joins Illumina with more than 20 years of leadership and legal experience at health care-focused technology companies. Most recently, he was Vice President, General Counsel for North and Latin America and Corporate Director of Global Intellectual Property at bioMerieux. In this role, he was responsible for global intellectual property matters and legal matters in North and Latin America. Prior to bioMerieux, he was General Counsel of BioDelivery Sciences International, a specialty pharmaceutical company; and oversaw US intellectual property in a variety of positions with Glaxo, GlaxoWellcome and GlaxoSmithKline. Mr. Dadswell holds a LLM in patent law and trade regulation from The George Washington University Law School, a JD from the Thomas M. Cooley Law School and a bachelor's in science from Ferris State University.

Basic Compensation

Total Annual Compensation, USD 388,703
Restricted Stock Awards, USD 2,273,700
Long-Term Incentive Plans, USD --
All Other, USD 44,602
Fiscal Year Total, USD 2,707,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

William Rastetter

--

Francis deSouza

6,373,520

Jay Flatley

14,856,400

Marc Stapley

4,137,130

David Walt

--

Mostafa Ronaghi

2,079,570
As Of  27 Dec 2014
Search Stocks